Veerle Leenaerts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Veerle Leenaerts has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Jos Callens
Faculty of Medicine, Catholic University of Leuven, Belgium
1 shared publicationMichael Staes
Faculty of Medicine, Catholic University of Leuven, Belgium
1 shared publicationPieter Monballyu
Faculty of Medicine, Catholic University of Leuven, Belgium
1 shared publication
Latest Publications
- Open Access
- 19 October 2021
- Published by European Medical Group in EMJ Respiratory
- p. 79-85
Pulmonary Embolism in Vaccine-Induced Thrombotic Thrombocytopaenia: Under-Reported?
Vaccination is currently the most powerful tool for controlling the COVID-19 pandemic.1 In large randomised controlled trials, the approved vaccines have shown good efficacy and safety.2 However, there is increasing concern about the safety of the adenovirus-based COVID-19 vaccines of AstraZeneca (ChAdOx1 nCoV-19) and Janssen (Ad26.COV2.S).
- 19 October 2021
- Published by European Medical Group in EMJ Respiratory
- p. 79-85
Open AccessPulmonary Embolism in Vaccine-Induced Thrombotic Thrombocytopaenia: Under-Reported?
Vaccination is currently the most powerful tool for controlling the COVID-19 pandemic.1 In large randomised controlled trials, the approved vaccines have shown good efficacy and safety.2 However, there is increasing concern about the safety of the adenovirus-based COVID-19 vaccines of AstraZeneca (ChAdOx1 nCoV-19) and Janssen (Ad26.COV2.S).
- Open Access
- 31 December 2020
- Published by Openventio Publishers in Emergency Medicine (EM)
- Vol. 6 (1) , 6-8
Nebulized Tranexamic Acid for Hemoptysis
The synthetic antifibrinolytic drug, tranexamic acid, is widely used intravenously, orally and topically to treat various bleeding complications. In recent years, there has been increasing evidence of its use as inhalation drug for hemoptysis. In this review, the available literature about aerosolized tranexamic acid is listed.
- 31 December 2020
- Published by Openventio Publishers in Emergency Medicine (EM)
- Vol. 6 (1) , 6-8
Open AccessNebulized Tranexamic Acid for Hemoptysis
The synthetic antifibrinolytic drug, tranexamic acid, is widely used intravenously, orally and topically to treat various bleeding complications. In recent years, there has been increasing evidence of its use as inhalation drug for hemoptysis. In this review, the available literature about aerosolized tranexamic acid is listed.